Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This is a multicentre observational study with prospective and retrospective data collection and retrospective data collection and biological collection from patients with HBV/HDV co-infection.

Who May Be Eligible (Plain English)

Who May Qualify: - Age \> 18 years, - Presenting a chronic HDV infection (positive serology), - Who gave his written willing to sign a consent form before any intervention and the day of inclusion at the latest, - Affiliated to Health Insurance or to the "Aide Médicale d'Etat" (request for exemption pending). Who Should NOT Join This Trial: - Patient participating in another biomedical research with an exclusion period ongoing at inclusion, - Vulnerable patient (minor, adults legally protected: under judicial protection, guardianship, or supervision, persons deprived of their liberty). - Patients with predictable difficulties of follow-up according to the investigator. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age \> 18 years, * Presenting a chronic HDV infection (positive serology), * Who gave his written informed consent before any intervention and the day of inclusion at the latest, * Affiliated to Health Insurance or to the "Aide Médicale d'Etat" (request for exemption pending). Exclusion Criteria: * Patient participating in another biomedical research with an exclusion period ongoing at inclusion, * Vulnerable patient (minor, adults legally protected: under judicial protection, guardianship, or supervision, persons deprived of their liberty). * Patients with predictable difficulties of follow-up according to the investigator.

Treatments Being Tested

OTHER

Blood draw for the laboratory assessment

Blood sampling for the biobank and, in addition, as sub-studies are planned on sub-groups of patients, additional blood samples are planned for the patients in these sub-studies.

Locations (20)

CHU of Angers
Angers, France
Centre Hospitalier de la région annécienne
Annecy, France
Avicenne Hospital - Hepatology
Bobigny, France
Avicenne Hospital
Bobigny, France
Haut Lévêque Hospital
Bordeaux, France
Estaing Hospital
Clermont-Ferrand, France
Beaujon Hospital
Clichy, France
Centre Hospitalier Intercommunal
Créteil, France
Henri Mondor Hospital
Créteil, France
Bocage Hospital
Dijon, France
Michallon Hospital
Grenoble, France
Claude Huriez Hospital
Lille, France
Dupuytren Hospital
Limoges, France
Croix Rousse Hospital
Lyon, France
Edouard Herriot Hospital
Lyon, France
Hôpital de la Croix Rousse
Lyon, France
SAint Joseph Hospital
Marseille, France
Saint Eloi Hospital
Montpellier, France
Hotel Dieu Hospital
Nantes, France
Hôtel-Dieu Hospital
Nantes, France